Valuation: CALYXTPAR

Market Cap 90.19M 80.89M 73.92M 67.48M 127M 8.48B 131M 891M 355M 4.52B 339M 331M 14.28B P/E 2026 *
-0.82x
P/E 2027 * -1.55x
Enterprise Value 90.19M 80.89M 73.92M 67.48M 127M 8.48B 131M 891M 355M 4.52B 339M 331M 14.28B EV / Sales 2026 *
17.4x
EV / Sales 2027 * 7.26x
Free-Float
73.66%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2026-06-07
Chief Tech/Sci/R&D Officer 57 2013-12-31
Chief Executive Officer 63 2025-02-23
Director TitleAgeSince
Chairman 72 2000-12-31
Director/Board Member 63 2000-12-31
Chairman 82 2025-08-05
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Free

Director

77,586 0.1477%
6/2/26 Free

Chief Executive Officer

77,586 0.1477%
6/2/26 Free

Director

64,748 0.1232%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.93% - - 90.19M
+2.63%-0.32%+22.75%+52.69% 257B
-3.36%+4.81%-17.34%+63.31% 157B
+1.73%-0.85%+9.29%+17.76% 162B
-4.23%+1.83%-56.84%-19.05% 61.96B
+1.31%+11.01%+23.90%+52.22% 58.73B
-0.76%+4.13%+0.84%-6.12% 55.42B
-2.05%-2.95%+4.30%+54.85% 49.18B
+1.73%-0.06%+18.49%+62.52% 49.27B
+1.00%-1.11%+23.29%+81.48% 44.96B
Average -0.20%+1.52%+3.19%+39.96% 89.6B
Weighted average by Cap. +0.26%+1.20%+5.29%+41.71%

Financials

2026 *2027 *
Net sales 5.19M 4.66M 4.26M 3.89M 7.32M 488M 7.55M 51.32M 20.47M 261M 19.5M 19.08M 823M 12.43M 11.15M 10.19M 9.3M 17.52M 1.17B 18.08M 123M 48.97M 623M 46.65M 45.65M 1.97B
Net income -66.51M -59.66M -54.52M -49.77M -93.77M -6.25B -96.73M -657M -262M -3.34B -250M -244M -10.53B -61.4M -55.07M -50.33M -45.95M -86.57M -5.77B -89.29M -607M -242M -3.08B -230M -226M -9.72B
Net Debt - -
Projected Income Statement - Annual - CALYXTPAR
Logo CALYXTPAR
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CALYXTPAR
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.180USD
Average target price
14.33USD
Spread / Average Target
+1,114.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CALYXTPAR
  1. Stock Market
  2. Stocks
  3. CLXT Stock